American College of Lifestyle Medicine urges remission as chronic disease goal

ST. LOUIS—The American College of Lifestyle Medicine (ACLM) has launched Project Remission, a new initiative urging healthcare systems to rethink chronic disease goals. Rather than focusing solely on symptom control, the project emphasizes the possibility of remission and meaningful health restoration when clinical care targets underlying causes.

Project Remission is built on scientific evidence and implementation experience from real-world practice. It challenges the long-held assumption that chronic conditions must progress inevitably over time, proposing that lifestyle-driven root-cause management can produce measurable, clinically relevant improvements.

The initiative spotlights high-impact conditions that often share common drivers, including type 2 diabetes, hypertension, and obesity. By concentrating on shared upstream mechanisms—such as metabolic dysregulation, dietary patterns, physical inactivity, stress physiology, and sleep-related factors—the project aims to demonstrate how coordinated lifestyle interventions can change disease trajectories.

With chronic and mental health conditions accounting for a substantial share of U.S. healthcare spending, Project Remission frames root-cause strategies as an urgent shift in care design. The central message is that long-term management alone may not be the best standard when remission is achievable for some patients.

“Chronic disease care may fail most by not asking what is truly possible,” said ACLM CEO John Findley, MD, CPE. “The science is clear that remission may be achievable for some patients when we address the root causes of disease—leading to better outcomes, lower costs, and improved quality of life.”

ACLM describes Project Remission as a platform combining educational materials, clinical evidence, implementation resources, and examples from clinicians and organizations using remission-focused care models. It also provides frameworks and training intended to help health systems translate research into routine practice workflows.

The project builds on ACLM’s earlier collaboration, Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, launched in March 2026. That digital film series featured clinicians, health systems, and organizations implementing lifestyle medicine in practice, alongside patient accounts of health journeys.

“Among people with type 2 diabetes, we have clear evidence that remission of conditions often considered permanent is possible, sometimes even after long disease duration,” said ACLM Senior Director of Research and Quality Micaela Karlsen, PhD, MSPH. She added that hypertension can respond rapidly to lifestyle intervention and that addressing metabolic and lifestyle factors can influence multiple conditions simultaneously.

Explore Project Remission resources at https://projectremission.org/.